Infliximab Is Effective in Acute but not Chronic Childhood Ulcerative Colitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 39, Issue 2, 2004, Pages 166-170

  Russell, George H ^a   Katz, Aubrey J ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Adolescent; Inflammatory bowel disease; Infliximab; Pediatric; Ulcerative colitis

Indexed keywords

GASTROINTESTINAL AGENT; INFLIXIMAB; MONOCLONAL ANTIBODY;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC DISEASE; COMPARATIVE STUDY; FEMALE; HOSPITALIZATION; HUMAN; INFUSION; MALE; REMISSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; CHILD; CHRONIC DISEASE; COLITIS, ULCERATIVE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INFUSIONS, PARENTERAL; MALE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 16644369357     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/00005176-200408000-00008     Document Type: Article

References (8)

1. Hyams J, Davis P, Grancher K, et al. Clinical outcomes of ulcerative colitis in children. J Pediatr 1996;129:81-8.
2. Lichtiger S, Present D, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841-5.
3. Mamula P, Markowitz J, Brown K, et al. Infliximab as a novel therapy for pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr 2002;34:307-11.
4. Chey W. Infliximab in refractory ulcerative colitis. Inflamm Bowel Dis 2001;7(Suppl):S30-3.
5. Sands B, Tremaine W, Sandborn W, et al. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis 2001;7:83-8.
6. Tolia V, Thomas R, Hyams J, et al. Multicenter review of infliximab use as a rescue therapy for pediatric ulcerative colitis (UC). J Pediatr Gastroenterol Nutr 2003;37:339.
7. Su C, Salzberg B, Lewis J, et al. Efficacy of alpha tumor necrosis factor therapy in patients with ulcerative colitis. Am J Gastroenterol 2002;57:2577-84.
8. Baert F, Noman M, Vermeire S, et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn’s disease. N Engl J Med 2003;348:601-8.